Answer Lists using this Answer Code

Answer ListAnswer List NameExternally Defined
LL1002-6PhenX05_15_30D cereal amtN
LL1087-7PhenX06_10_res water supplyN
LL1106-5PhenX06_28_workspace floor materialN
LL1108-1PhenX06_30_home repairsN
LL1117-2PhenX07_08_gallstone dx methodN
LL1125-5PhenX07_16_chemo drugsN
LL1126-3PhenX07_17_hormone therapy drugsN
LL1132-1PhenX07_23_stop pain med reasonN
LL1141-2PhenX08_08_child beverage between mealsN
LL1153-7PhenX08_20_dentist visit reasonN
LL1154-5PhenX08_21_pain durationN
LL118-1CR_160_RaceN
LL119-9CR_161_Race2N
LL1191-7PhenX10_02_male infertility probsN
LL1195-8PhenX10_06_birth control methodsN
LL1213-9PhenX10_24_natural hormonesN
LL1232-9PhenX10_43_pregnancy outcomeN
LL1245-1PhenX11_07_child strabismus txN
LL1246-9PhenX11_08_myopia txN
LL1248-5PhenX11_10_glaucoma dropsN
LL127-2CR_170_Race coding systemN
LL133-0CR_1790_Follow up sourceN
LL1337-6PhenX12_67_job scheduleN
LL1338-4PhenX12_68_job shiftN
LL1423-4PhenX14_17_aids for walkN
LL1431-7PhenX14_25_reason no actigraphN
LL1443-2PhenX03_15_lifetime drug use typeN
LL1474-7PhenX07_39_ menopause causeN
LL1543-9Phenx11_42_relativesN
LL1549-6Phenx11_47_glaucoma treatmentN
LL1566-0PhenX13_43_body partN
LL1628-8PhenX18_11_languagesN
LL1632-0PhenX18_15_fracture confirmation sourceN
LL1633-8PhenX18_16_hip fracture locationN
LL1634-6PhenX18_17_fracture treatmentN
LL1635-3PhenX18_18_fracture circumstancesN
LL1636-1PhenX18_19_trauma locationN
LL1637-9PhenX18_20_time of fractureN
LL1639-5PhenX18_22_fracture location detailN
LL1654-4PhenX18_26_race, ethnicityN
LL1658-5PhenX19_04_Dr. reported pain causeN
LL1660-1PhenX19_06_reason Dr. visitN
LL1672-6PhenX19_18_diagnostic, staging procedureN
LL1677-5PhenX19_23_CA histopathology typeN
LL1693-2PhenX19_39_bleeding siteN
LL1735-1FeedingTypeN
LL1736-9MaternalFactorsN
LL1752-6PhenX21_02_reason for experienceN
LL1766-6PhenX16_07_main symptomN
LL1772-4PhenX16_13-medical hxN
LL1775-7PhenX16_16_infectious diseasesN
LL1832-6NEMSIS_45_protocol usedN
LL1862-3PhenX19_45_initial visit reasonN
LL1865-6PhenX19_48_autoimmune diseasesN
LL1874-8FMQAI_03_self dialysis trainingN
LL1884-7FMQAI_05_Reason no transplant info givenN
LL1889-6FMQAI_10_Dialysis at time of deathN
LL1890-4FMQAI_11_Reason therapy disconintuedN
LL1891-2FMQAI_12_Payment sourceN
LL1898-7PhenX15_11N
LL1910-0FMQAI_17_Place of deathN
LL1914-2SAMSHA_01_sources of stressN
LL1916-7SAMSHA_03_occupational statusN
LL1955-5PhenX16_25_Booster typeN
LL1974-6NEMSIS_83_mech of injuryN
LL2003-3OPTIMAL_Mobility aidsN
LL2023-1NIH Stroke Scale IntervalN
LL2104-9ESRD-Erythropoiesis-Stimulating AgentN
LL2105-6ESRD-medication routeN
LL2116-3ESRD - information sourceN
LL2121-3NEMSIS-ECG typeN
LL214-8CR_450_Site coding systemN
LL2142-9ESRD-facilities-certified programN
LL216-3CR_470_Morphology coding systemN
LL2164-3ESRD-graft assessment frequencyN
LL2165-0ESRD-non-oral vitamin D analogN
LL2166-8ESRD-oral vitamin D analogN
LL2167-6ESRD-dialysis access exam frequencyN
LL2172-6ESRD-IV iron type prescribedN
LL2173-4ESRD-oral iron type prescribedN
LL2190-8RHEA-perineal tear classN
LL2205-4CARE-LTCH - discharge locationN
LL2239-3AdenovirusN
LL2266-6HCoVN
LL2267-4hMPV genotypeN
LL2272-4RSV typeN
LL2274-0RhinovirusN
LL2344-1VAERS_Relation to patientN
LL236-1CR_930_Pathology stagerN
LL2458-9Reason CCHD NBS not performedN
LL2513-1Type of place where birth occurredN
LL2517-2Cephalic-Breech-OtherN
LL2532-1Death certificate_Transport Role of DecedentN
LL2563-6NTDS_F01_Payment sourceN
LL259-3OASIS_M0300_Current residenceN
LL2685-7NTDS_DG_01_Co-morbid ConditionsN
LL2759-0NTDS_Q_01_Hospital ComplicationsN
LL2762-4NTDS_P_07_Transport modeN
LL2915-8CDC.CS_13_Mother's raceN
LL2917-4CDC.CS_15_Mother's marital statusN
LL2921-6CDC.CS_19_Mother's clinical stage of syphilisN
LL2922-4CDC.CS_20_Mother's surv stage of syphilisN
LL2925-7CDC.CS_22_Mother's treatmentN
LL2930-7CDC.CS_32_Signs of CSN
LL2936-4CDC.CS_17_Treponemal test typeN
LL3012-3PCORI_Information data sourceN
LL3017-2Discharge vital statusN
LL3031-3Patient Residence TypeN
LL3068-5MSCDM_Admitting SourceN
LL3178-2US state or other_specifyN
LL3179-020150106-APTASet1_2N
LL3182-420150106-APTASet1_5N
LL3185-720150106-APTASet1_8N
LL3187-320150106-APTASet1_10N
LL3195-620150106-APTASet1_18N
LL3254-1Cardiac stress test typesN
LL331-0OASIS_M0900_Nursing home admissionN
LL3322-6Gender identityN
LL3323-4Sexual orientationN
LL350-0ART_1_Entry pointN
LL3591-6Visual evoked potential resultsN
LL3592-4Electroretinography resultsN
LL3638-5Heparin|Saline|None|Other|UnknownN
LL3656-7[NHCS] Surgery 24H post-op follow-up outcomesN
LL3676-5[NHCS] Outpatient visit discharge dispositionN
LL3677-3[NHCS] ED discharge dispositionN
LL3699-7Coronary artery segmentsN
LL3702-9Cardiac procedure complicationsN
LL371-6HL79033_Program nameN
LL3721-9Cardiac cath access sitesN
LL3722-7[NEI] Amblyopia typeN
LL3723-5[NEI] Coloboma locationN
LL3724-3[NEI] Color vision findingsN
LL3725-0[NEI] Color vision test methodN
LL3727-6[NEI] Findings supporting myopathyN
LL3728-4[NEI] Type of congenital cranial dysinnervation (CN
LL3729-2[NEI] Gross eye defectsN
LL373-2HL79034_Pt escortN
LL3730-0[NEI] Eye-related MRI findingsN
LL3731-8[NEI] Inheritance pattern from family historyN
LL3734-2[NEI] Oculary historyN
LL3735-9[NEI] Corneal dystrophy typeN
LL3738-3[NEI] Strabismus typeN
LL3739-1[NEI] Ophthalmologic disease related systemic findN
LL3740-9[NEI] Tetraparesis typeN
LL3741-7[NEI] Tissue types positive for axonal spheroidsN
LL3743-3[NEI] Ocular alignment findingsN
LL3744-1[NEI] Nystagmus null-point head postureN
LL3747-4[NEI] Oscillatory potentials findingsN
LL3748-2[NEI] Reference electrode locationN
LL3750-8[NEI] ERG procedure standard followedN
LL3751-6[NEI] ERG vendor and model usedN
LL3752-4[NEI] ISCEV standard protocol usedN
LL3756-5[NEI] Ocular motility findingsN
LL3757-3[NEI] Anterior chamber angle findingsN
LL3758-1[NEI] Visual field defect findingsN
LL3760-7[NEI] Visual field findings by confrontatoinN
LL3761-5[NEI] Ocular fundus angiography findingsN
LL3762-3[NEI] Pupillary response findingsN
LL3763-1[NEI] Optical coherent tomography (OCT) findingsN
LL3764-9[NEI] Chorioretinal findingsN
LL3767-2[NEI] Glaucoma typeN
LL3768-0[NEI] Optic nerve exam findingsN
LL3771-4[NEI] Objective refraction methodN
LL3773-0[NEI] Anterior chamber slit lamp findingsN
LL3774-8[NEI] Conjunctiva and sclera slit lamp findingsN
LL3775-5[NEI] Cornea slit lamp findingsN
LL3776-3[NEI] Iris slit lamp findingsN
LL3777-1[NEI] Lens slit lamp findingsN
LL3779-7[NEI] Lids and lashes slit lamp findingsN
LL3780-5[NEI] Pupil shape slit lamp findingsN
LL3781-3[NEI] Vitreous slit lamp findingsN
LL3787-0[NEI] Nystagmus typeN
LL3788-8[NEI] Refraction methodN
LL3816-7Nursing WDL or assessment textN
LL3860-5DBS collection methodN
LL3871-2[NEI] VEP resultN
LL3872-0[NEI] PigmentationN
LL3882-9[APTA] Surgery relevant to physical therapyN
LL3885-2Muscle strengthN
LL3896-9Burial | Crem | Don | Entomb | Rem |OthN
LL3943-9Absent | Pancreas | Spleen | Liver | OtherN
LL3944-7Gastric cancer surgical resection typesN
LL3958-7Devices used for cardiac catheterizationN
LL3971-0NCHS_Tabulated RaceN
LL3991-8CDC_Transmission settingN
LL4003-1Sources used to estimate activity metabolic rateN
LL4004-9Sources used to adjust exercise METN
LL4005-6Sources used for predicted RMRN
LL4006-4Sources used for population RMRN
LL4012-2Yes|Other_commentN
LL402-9MERS_TH_2_ServiceN
LL4022-1Physical therapy degreeN
LL4023-9Physical therapy highest educationN
LL4024-7ClinVar|COSMIC|OtherN
LL4025-4Allelic phaseN
LL403-7MERS_TH_3_Event typeN
LL4037-9Calorimetry methodsN
LL404-5MERS_TH_4_Med eventN
LL405-2MERS_TH_5_Proc-tx-surg eventN
LL4052-8Prenatal test | Prison entry | Provider | ClusterN
LL406-0MERS_TH_6_Food-nutrition eventN
LL4064-3Gene sequencing | Serology | RT-PCR | OtherN
LL408-6MERS_TH_8_Accident eventN
LL4081-7Apical|Bladder neck|Ant|Post|Post-lat|Post|OtherN
LL409-4MERS_TH_9_Nursing care eventN
LL410-2MERS_TH_10_Equip-device eventN
LL411-0MERS_TH_11_Lab eventN
LL4118-7Outdoor activitiesN
LL412-8MERS_TH_12_Transfusion eventN
LL4120-3PCORI_response_methodN
LL4121-1PCORI_response_sourceN
LL4122-9yes|no|no info|unk|otherN
LL4123-7PCORI_Smoked_v_non-smoked_tobaccoN
LL4124-5Expedite|Routine|Stat|NI|UN|OTN
LL4125-2Laboratory|POC|NI|UN|OTN
LL4126-0PCORI_Cause_of_death_rankN
LL413-6MERS_TH_13_Admin eventN
LL4135-1Platelet aggregation inhibitorsN
LL4136-9Anticoagulant medicationsN
LL4137-7Preoperative proceduresN
LL414-4MERS_TH_14_Complaint eventN
LL415-1MERS_TH_15_Eviron-safety eventN
LL416-9MERS_TH_16_Crime-harm-disappear eventN
LL417-7MERS_TH_17_Adverse eventN
LL418-5MERS_TH_18_Tech contributing factorN
LL419-3MERS_TH_19_Org contributing factorN
LL420-1MERS_TH_20_Comm-documentation factorN
LL4207-8Imputed parts of DODN
LL4208-6Excellent|Fair|Poor|NI|UN|OTN
LL421-9MERS_TH_21_Environ contributing factorN
LL422-7MERS_TH_22_Pt contibuting factorN
LL423-5MERS_TH_23_Staff contributing factorN
LL424-3MERS_TH_24_Delay-premature factorN
LL4347-2Low grade|High grade|NA|Cannot assess|OtherN
LL4348-0Surgical margin typesN
LL4352-2Methylation techniquesN
LL4353-0Reason vaccine not receivedN
LL4356-3RelationshipsN
LL4360-5Physician|Healthcare professional|Parent|OtherN
LL4363-9RV genotypeN
LL4376-1[CAP] Procedure for tumor specimen collectionN
LL4384-5[CAP] Architectural PatternsN
LL4390-2CAP_breast specimen originN
LL4421-5Prescreen Influenza SampleN
LL4428-0CMS Living arrangementN
LL4436-3[CAP] Melanoma ProcedureN
LL4455-3[CAP] Additional Pathologic FindingsN
LL4456-1[CAP] LymphadenectomyN
LL4463-7NKDEP_RRT treatment preferenceN
LL4470-2CMS_LCDS Payer informationN
LL4472-8CMS_LCDS Discharge locationN
LL4562-6[CAP] Microcalcifications in breast cancerN
LL4564-2[CAP] MarginsN
LL4572-5[CAP] Melanoma marginsN
LL4575-8Provider roleN
LL4579-0Reason for no birth controlN
LL4631-9Father of baby | Other relative |Hospital employeeN
LL4636-8NIDDK_CKD education topicsN
LL4653-3Role of person in accidentN
LL4655-8Mechanism of force that caused injuryN
LL4657-4Intoxication causeN
LL4674-9Burial | Crem | Hospital | Donation |Removal | OthN
LL4703-6Categories of LeukocytesN
LL4705-1NIDDK_patient health goalsN
LL4706-9NIDDK_functional areasN
LL4707-7NIDDK_Health eventsN
LL4708-5NIDDK_SymptomsN
LL4709-3NIDDK_Mental health issuesN
LL4710-1NIDDK_ChallengesN
LL4711-9NIDDK_Treatment affected by challengesN
LL4747-3NTDS_DG_01_Co-morbid Conditions_v2018N
LL4748-1NTDS_ED_17_Drug ScreenN
LL4749-9Blunt|Burn|Blow|Shot|Stabbed|Penetrating|OtherN
LL4750-7NTDS_F01_Payment source_v2N
LL4752-3NTDS_I_14_Protective devicesN
LL4753-1NTDS_Q_01_Hospital Complications_v2N
LL484-7DEEDS4.05_Source of ReferralN
LL4904-0Body position &or immobilizersN
LL4906-5Factors related to rescueN
LL4939-6Alone | Family/Relatives | Friends | AttendantN
LL494-6DEEDS4.27_1st temp siteN
LL4955-2Anticoagulant medications - ADAPTABLEN
LL4960-2ADAPTABLE Race listN
LL4963-681 mg | 162 mg | 325 mgN
LL4999-0Circulatory assistive devicesN
LL5-0MDS_90_Admitted fromN
LL5007-1Molecular lab test antibiotic resistance methodN
LL5008-9Phenotypic method for antibiotic resistanceN
LL5009-7APTA_Airway clearance techniquesN
LL5011-3APTA_Motor function trainingN
LL5012-1APTA_Therapeutic exerciseN
LL5013-9APTA_Functional trainingN
LL5015-4APTA_Integumentary repair and protectionN
LL5016-2APTA_Instruction providedN
LL5017-0APTA_Manual therapy techniquesN
LL5018-8APTA_Biophysical agentN
LL5021-2APTA_Movement system diagnosisN
LL5023-8Reason for difficult intubationN
LL5025-3Reason rescue operation was canceledN
LL5028-7German DIMD_Mental statusN
LL5054-3Manual|Assist|Ctrl|Assist-Ctrl|MMV|OtherN
LL5110-3EOC public document typesN
LL5202-8EOC Inter-agency document typesN
LL5334-9PRAPARE_Food|Util|Med|Phone|Clothing|ChildCare|OthN
LL5348-9PRAPARE_RaceN
LL5359-6Vomiting|Swollen feet|Backaches|OtherN
LL5389-3Setting of exposure to hazardN
LL5496-6Religious beliefN
LL5542-7Intubation tube typesN
LL5544-3EMS Positions and/or immobilizersN
LL5552-6COVID19 exposuresN
LL5563-3Reasons specimen not collectedN
LL5565-8Mode of discovery for tumorN
LL5580-7Birth locationN
LL5598-9Animal exposureN
LL5625-0Substances - NIDA-ASSISTN
LL57-1CR_1040_Cancer stagerN
LL5713-4AAPCHO - Services ProvidedN
LL5721-7Debridement methodN
LL5739-9CMS_LCDSv4 Discharge locationN
LL5770-4AAPCHO - Provided ServicesN
LL5826-4Spine Tango - Work statusN
LL5827-2Spine Tango - Follow-up IntervalN
LL5828-0Spine Tango - Therapeutic goals/measuresN
LL5829-8Spine Tango - Meds Spinal surgery/pathologyN
LL5832-2Spine Tango - Complications TypeN
LL5833-0Spine Tango - Therapeutic consequencesN
LL5834-8Sping Tango - Individual ConsequencesN
LL5835-5Spine Tango - RehabilitationN
LL5838-9Spine Tango - Degeneration TypeN
LL5839-7Spine Tango - Deformity TypeN
LL5840-5Spine Tango - Predominant EtiologyN
LL5841-3Spine Tango - Fracture/Trauma TypeN
LL5845-4Pathological fracture causeN
LL5850-4Infection specificationN
LL5851-2Affected structuresN
LL5852-0Spine Tango - Tumor TypeN
LL5853-8Spine Tango - Tumor localizationN
LL5862-9Vaccine administration locationN
LL5882-7COVEX Work SituationN
LL5883-5COVEX Work SettingsN
LL5889-2COVEX - Household MembersN
LL5893-4EuroSpine Repeat Surgery ReasonN
LL5897-5EuroSpine - Main pathologyN
LL5901-5EuroSpine - Therapeutic goalsN
LL5903-1Anterior accessN
LL5904-9Posterior accessN
LL5906-4EuroSpine - Surgeon CredentialsN
LL5907-2EuroSpine - TechnologyN
LL5912-2DecompressionN
LL5914-8Fusion promoting measuresN
LL5915-5Fusion materialN
LL5916-3EuroSpine - Stabilized rigidN
LL5917-1Deformity correctionN
LL5918-9Stabilization motion preservingN
LL5919-7Other surgial measuresN
LL5920-5Intraop adverse eventN
LL5921-3Measures during index surgeryN
LL5922-1Intraop general complicationsN
LL5923-9PostOp Surgical ComplicationsN
LL5924-7PostOp General ComplicationsN
LL5925-4Re-intervention after index surgeryN
LL5961-9Spine Tango - Degeneration Type_SecondaryN
LL5968-4Spine Fusion MeasuresN
LL5970-0Injury associated activityN
LL5971-8Reason CPR discontinuedN
LL5973-4DIMDI_Neurological assessmentN
LL5997-3Cryptosporidium speciesN
LL6006-2Employment SituationsN
LL6019-5Hearing Loss - ConfigurationN
LL6030-2CVD-19 - school age - reason not follow learningN
LL6049-2Reason for missed appointments w/codeN
LL6050-0Therapeutic Antibody TreatmentN
LL6053-4Reason for missed appointments w/o codeN
LL6057-5Reason for missed medication w/codeN
LL6061-7Expense coverageN
LL6080-7Organs donatedN
LL6086-4Sources of informationN
LL6087-2LASIK Information SourcesN
LL6095-5Medical attention typeN
LL6100-3NEI Race ListN
LL613-1CR_193N
LL6167-2Internet typesN
LL6168-0Education providerN
LL6169-8Post high school plansN
LL6194-6Reason not to repeat/recommend procedureN
LL6197-9Yes|No|OtherN
LL6199-5Child care providersN
LL622-2USSG-FHT genderN
LL6226-6Specular Microscopy Analysis MethodN
LL6242-3Assisted mobility devicesN
LL6266-2POLST discuss partN
LL636-2MDSv3_A0800N
LL637-0MDSv3_A2100N
LL6566-5PhenX11701_Sexual orientation description otherN
LL6574-9Gender identity, otherN
LL6576-4Biological sex assigned at birth, otherY
LL66-2CR_1130_Peds staging coding systemN
LL67-0CR_1140_Peds stagerN
LL6912-1Significant otherN
LL6944-4CMS HOPE Payer InfoN
LL7063-2ACORN_Who provided the screener responsesN
LL7064-0ACORN_Who was the screener administered byN
LL7073-1ACORN_Where you lived for MOSTN
LL7237-2Housing #1A, #1BN
LL7242-2Housing #17A, 17BN
LL7361-0JED_Adverse event actionsN
LL7372-7JED_Endoscopic procedure_headneckN
LL7378-4JED_Endoscopic procedure_esophagusN
LL7384-2JED_Endoscopic procedure_stomachN
LL7389-1JED_Endoscopic procedure_duodenumN
LL7394-1JED_Endoscopic procedure_colonN
LL7399-0JED_Endoscopic procedure_smallbowelN
LL740-2Special circumstancesN
LL7552-4TESTN
LL777-4OASIS-C_M1032N
LL8-4MDS_156_Primary languageN
LL830-1NBS eventsN
LL869-9AnginaLocN
LL870-7AnginaRadN
LL871-5AnginaTypeN
LL889-7DVTDxSourceN
LL939-0NAACCR_7480N
LL987-9TIMP_27_EnvironmentN